Drug-class specific impact of antivirals on the reproductive capacity of HIV.
Predictive markers linking drug efficacy to clinical outcome are a key component in the drug discovery and development process. In HIV infection, two different measures, viral load decay and phenotypic assays, are used to assess drug efficacy in vivo and in vitro. For the newly introduced class of i...
Main Authors: | Max von Kleist, Stephan Menz, Wilhelm Huisinga |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-03-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC2845651?pdf=render |
Similar Items
-
HIV quasispecies dynamics during pro-active treatment switching: impact on multi-drug resistance and resistance archiving in latent reservoirs.
by: Max von Kleist, et al.
Published: (2011-03-01) -
Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis.
by: Sulav Duwal, et al.
Published: (2019-01-01) -
Estimating HIV-1 fitness characteristics from cross-sectional genotype data.
by: Sathej Gopalakrishnan, et al.
Published: (2014-11-01) -
Mathematical Modelling of the Molecular Mechanisms of Interaction of Tenofovir with Emtricitabine against HIV
by: Sara Iannuzzi, et al.
Published: (2021-07-01) -
Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV
by: Max von Kleist, et al.
Published: (2020-08-01)